In California’s latest loss of the COVID-19 vaccine rollout, the state’s top epidemiologist Sunday night recommended that clinics in southern California contain thousands of doses after a series of allergies.
An unusually high number of people experienced an anaphylactic shock, a severe allergic reaction that required immediate medical attention after receiving a shot of a modern vaccine at a San Diego vaccination site, the statement said Sunday night . While the number was less than 10, the group of negative reactions prompted the California Department of Public Health to stop the administration of some 330,000 doses from the batch, which was distributed throughout the state until an investigation was completed.
“Our goal is to provide the COVID vaccine safely, rapidly and evenly,” Pan said in the statement. “With a lot of modern vaccines administered in a community-vaccine clinic, a more than usual number of possible allergic reactions were reported. … After recognizing the extreme abundance of caution and the extremely limited supply of vaccines, we are recommending Are that providers use the other available vaccine list and the CDC, FDA, Modern and State are complete. We will provide an update as we learn more. “
The responses reported at the San Diego Clinic were similar to the rare incidents that the Center for Disease Control and Prevention had warned and cautioned for. In California, vaccination sites monitor recipients on site for 15 minutes for adverse reactions. The cluster in Southern California was the first in a nation related to a subject sufficient to prevent use altogether.
The dose in batches is still less than 10% of all vaccine doses allocated to California by 330,000 modern volumes. But according to the 3.5 million dosages the state received, according to CDC figures, it had taken more than 1 million doses less than a third. According to CDC data, on a per capita basis, only five states have fewer residences than California residents.
Severe allergic reactions, while possible, are believed to be extremely rare in modern and Pfizer vaccines. Officials said the rate of anaphylaxis in the modern vaccine was expected to be one per 100,000. Several federal and state agencies had opened investigations into the cases, saying they would have more information later this week.